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A 9-year-old, intact male, Brie’s shepherd dog, with a 10-day history of depression and tachypnoea developed signs of central
neurological dysfunction. 16 Multislice Computed Tomography (CT) pre- and postcontrast studies of the brain revealed a single
intra-axial homogeneous well-circumscribed hyperattenuating (+/− 62 HU) and noncontrast-enhancing area, 5mm in diameter,
in the caudal part of the mesencephalon. This finding was highly suggestive of a haemorrhagic event. A pituitary-dependent
hyperadrenocorticism (PDH) was identified and is considered likely to be the underlying cause. A repeat CT scan examination, 2
months later, showed almost complete resolution of the brain lesion. The present case describes a solitary 5mm diameter lesion:
the result of intracranial haemorrhage in a dog with presumed PDH.
1. Case Presentation
A 9-year-old, entire male, Brie’s shepherd dog, was referred
with a 10-day history of acute depression and tachypnoea.
On clinical evaluation, the only abnormalities detected were
obtundation and superficial tachypnoea. A complete blood
count, biochemistry profile, blood gas analysis, and urinalysis
revealed only a mild increase in serum GGT, ALT, and
cholesterol. Systolic blood pressure (Doppler method) was
within normal limits. Thoracic radiographs were unremark-
able. Three days later, the dog developed acute neurological
signs consistent with central dysfunction with right-sided
amaurosis, ventromedial strabismus of the left eye, and left-
sided Horner’s syndrome.
16 Multislice Computed Tomography pre- and postcon-
trast studies of the brain were performed. A single intra-
axial, homogeneous, well-circumscribed, irregularly shaped,
hyperattenuating (+/− 62HU), and noncontrast-enhancing
area of 5mm diameter was observed in the caudal part of the
mesencephalon, mildly left-sided, exerting a mild mass effect
on the surrounding structures and associated with dilation
of the ventricular system (Figure 1). This finding was highly
suggestive of a haemorrhagic event. Potential underlying
causes included hypertension, thromboembolism or coagu-
lopathy, or haemorrhagic tumours (haemangioma, haeman-
giosarcoma, and haemorrhagic gliomas). Cerebrospinal fluid
collection was performed; protein levels and cell count were
within normal limits. A coagulation profile (prothrombin
time, activated partial thromboplastin time, and thrombin
time) was normal. Abdominal ultrasound showed a bilateral
severe, well marginated, homogeneous enlargement of right
and left adrenal glands measuring, respectively, 1,5 cm and
2 cm. PDH may therefore be suspected. Less likely, the
increase in size of the adrenal glands may occur secondary
to bilateral adrenal neoplasia, such as functional or non-
functional carcinoma and adenoma, phaeochromocytoma,
granuloma, or myelolipoma. The neurologic abnormalities
improved gradually until complete resolution 30 days after
the initial clinical presentation. At that time, a low-dose dex-
amethasone suppression test was performed and confirmed
the diagnosis of PDH (in both samples 4 and 8 hours after
the injection, the value was above the normal limits of 1 𝜇g,
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Figure 1: Transverse CT image of the brain prior to contrast
medium administration showing a small intra-axial hyperatten-
uating lesion in the mesencephalon and a moderate asymmetric
enlargement of the ventricular system.
Figure 2: Transverse CT image of the brain, 30 days later, showing
the absence of the lesion and the almost complete resolution of the
ventricular enlargement.
respectively, 1,68 and 3,06 𝜇g with a >50% reduction in the
4-hour sample compared to the basal cortisol value). The
CT scan was repeated 2 months later to follow the evolution
of the lesion and showed almost complete resolution of the
brain lesion, including resolution of the ventricular system
enlargement (Figure 2). The improvement in the CT scan
images corresponded with a complete resolution of clinical
signs. In both CT examinations, the pituitary gland appeared
within normal limits measuring 6×4×4mmwith a pituitary
gland/brain area ratio of <0,31.
Two months after initial presentation the patient was lost
to follow-up.
2. Discussion
Diagnosis of intracranial haemorrhage is based on CT and
MRI: the former is very sensitive and was previously the
primary diagnostic tool for detection of haemorrhage in
human medicine. MRI provides a more accurate estimate of
the stage of haemorrhage by identifying sequential patterns of
degradation of the haemoglobinmolecule during haematoma
transformation [1].
There is a linear relationship between CT attenuation,
protein content (mainly haemoglobin), and haematocrit. In
the early hours of haemorrhage, the lesion exhibits moderate
high-density values, because of freshly extravasated blood
characterized by cells interspersed with protein-rich serum.
The increase of haematocrit in the subsequent period gives
the lesion the aspect of a well-demarcated hyperattenuated
lesion, with Hounsfield units’ values reaching 60–80HU.
With clot retraction the CT attenuation values increase
to 80–100HU in the centre of the haematoma, while a
hypoattenuating halo surrounds the central nidus due to
serum extrusion and reactive vasogenic oedema. In theweeks
following the acute event the attenuation of the haematoma
decreases as proteolysis begins, even if themass effect persists.
Within weeks or months, the digestion of blood degradation
products by macrophages can lead to the total resolution of
the lesion, even if calcification, hypoattenuating area, focal
atrophy, or ventricular enlargement can be easily detected on
CT images and can represent the sequel of an old haematoma
[1].
Primary intracranial haemorrhage is less frequent than
secondary intracranial haemorrhage and is considered very
rare in animals [2]. Some neoplastic conditions may lead to
secondary intracranial haemorrhage because of concurrent
disseminated intravascular coagulopathy or because of bleed-
ing. Examples of such tumours include haemangiosarcoma
[3–5], haemangioma [6], oligodendrogliomas, glioblastomas,
ependymomas, or pituitary adenomas [4]. Many different
pathological conditions have also been associated with sec-
ondary intracranial bleeding: trauma [7], congenital vascular
malformations [8, 9], vasculitis [2], Angiostrongylus vasorum
infection [10, 11], and systemic arterial hypertension [10].
The diagnosis of hyperadrenocorticism (HAC) is chal-
lenging and none of the biochemical screening or differen-
tiating tests is perfect [12, 13]. The low-dose dexamethasone
suppression test is considered the test of choice, unless
iatrogenic HAC is suspected. The sensitivity of this test is
excellent ranging from 85 to 100%, but specificity is lower
ranging from 44 to 73%, especially when measured in a
population of sick dogs, affected by chronic disease [12, 13].
Because of the influence of possible concurrent nonadrenal
disease the dog described here was tested after a delay of 30
days, when it had recovered and was not showing clinical
signs. The dog in this study showed bilateral increase in
the size of the adrenal glands. This finding is consistent
with the diagnosis of HAC. Other differential diagnoses such
as bilateral nonfunctional adrenal neoplasia, granuloma, or
myelolipoma seem less likely, but could not be completely
ruled out.
In the present case, the pituitary gland appeared within
normal limits on CT examination, but one limitation is that a
dynamic CT examination was not performed. However, even
if dynamic CT provides very useful information in additional
to conventional contrast-enhanced CT, the absence of abnor-
malities on dynamic CT examination does not rule out the
presence of a microadenoma [14].
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The incidence of HAC in dogs with intracranial haem-
orrhage is at present unknown. In a study of Garosi et al.
[15], HAC was cited as a potential underlying cause of
cerebrovascular accident in dogs, but all reported cases
involved ischaemic infarction. In another study [16], one of 4
dogs with haemorrhagic stroke had been under treatment for
HAC for 8 months. The presence of a hypercoagulable state
in conjunction with mild to moderate systemic hypertension
leading to vascular lesions represents a possible explanation
for haemorrhagic stroke in dogs with HAC [4, 10]. Recently,
a study described concurrent medical conditions and long-
term outcomes in dogs with nontraumatic intracranial haem-
orrhage. In that study, 5 of 75 dogs had systemic hypertension
and 2/5 were diagnosed with HAC. In all 5 cases, MRI
examination showed multiple lesions less than 5mm in
size [10]. This is similar to what happens in people, where
systemic hypertension is commonly seen in association with
microbleeding, that is, multiple haemorrhages <5mm. The
dog in this case differed from what is typically described in
the literature because of the absence of hypertension detected
during the clinical examination and the presence of a solitary
lesion of 5mm in diameter. Therefore, it is reasonable to
postulate that in our case the relationship between HAC and
the intracranial lesion may not be related to a hypertensive
event; the pathogenesis remains unknown.
The absence of histological confirmation for both the
suspicion of intracranial haemorrhage and the pituitary-
dependentHAC represents a limitation in this case. However,
the resolution of the lesion on the second CT examination
and the absence of clinical signs two months after the
event support our suspicion of intracranial haemorrhage. On
the other hand given the positive low-dose dexamethasone
suppression test and the bilateral increase in adrenal gland
size we can postulate that pituitary-dependent HAC is the
most likely underlying disease, although this diagnosis could
not be confirmed.
In conclusion, the present case describes an intracranial
haemorrhage in a dog with suspected Cushing’s disease as a
single lesion of 5mm diameter.
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